Page 1 of Clinical Trials for Phase IIb, 734 Total Matches
- 1CompletedLast Updated: February 25, 2011Condition(s): Cystic Fibrosis
- 2RecruitingLast Updated: August 21, 2011Condition(s): Metastatic Castration Resistant Prostate Cancer (CRPC)
- 3CompletedLast Updated: May 26, 2010Condition(s): Rheumatoid Arthritis
- 4RecruitingLast Updated: January 25, 2012Condition(s): Non-Small-Cell Lung Carcinoma
- 5RecruitingLast Updated: May 2, 2012Condition(s): Lung Neoplasms
- 6CompletedLast Updated: March 3, 2008Condition(s): Leukoplakia; Periodontal Disease
- 7SuspendedLast Updated: March 29, 2010Condition(s): Shigella
- 8Completed
- 9CompletedLast Updated: March 19, 2012Condition(s): Hepatitis C Virus
- 10Active, not recruitingLast Updated: May 20, 2010Condition(s): Breast Cancer
- 11CompletedLast Updated: September 13, 2005Condition(s): Lung Cancer
- 12CompletedLast Updated: May 25, 2010Condition(s): Primary Insomnia
- 13Active, not recruitingLast Updated: June 17, 2011Condition(s): Lung Neoplasms; Carcinoma, Non-Small-Cell Lung
- 14CompletedLast Updated: January 18, 2010Condition(s): Celiac Disease
- 15CompletedLast Updated: July 18, 2006Condition(s): Sepsis
- 16Not yet recruitingLast Updated: May 7, 2012Condition(s): Chronic Phase Chronic Myeloid Leukemia
- 17RecruitingLast Updated: January 26, 2012Condition(s): Rheumatoid Arthritis
- 18RecruitingLast Updated: November 12, 2011Condition(s): Sarcoma
- 19CompletedLast Updated: August 18, 2009Condition(s): GERD Without Erosive Esophagitis
- 20TerminatedLast Updated: October 7, 2011Condition(s): Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Phase+IIb
